211 related articles for article (PubMed ID: 29632248)
1. Are Sphingolipids and Serine Dipeptide Lipids Underestimated Virulence Factors of Porphyromonas gingivalis?
Olsen I; Nichols FC
Infect Immun; 2018 Jul; 86(7):. PubMed ID: 29632248
[TBL] [Abstract][Full Text] [Related]
2. Serine dipeptide lipids of Porphyromonas gingivalis inhibit osteoblast differentiation: Relationship to Toll-like receptor 2.
Wang YH; Nemati R; Anstadt E; Liu Y; Son Y; Zhu Q; Yao X; Clark RB; Rowe DW; Nichols FC
Bone; 2015 Dec; 81():654-661. PubMed ID: 26409254
[TBL] [Abstract][Full Text] [Related]
3. Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.
Kanzaki H; Movila A; Kayal R; Napimoga MH; Egashira K; Dewhirst F; Sasaki H; Howait M; Al-Dharrab A; Mira A; Han X; Taubman MA; Nichols FC; Kawai T
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):452-462. PubMed ID: 28153611
[TBL] [Abstract][Full Text] [Related]
4. Porphyromonas gingivalis lipids inhibit osteoblastic differentiation and function.
Wang YH; Jiang J; Zhu Q; AlAnezi AZ; Clark RB; Jiang X; Rowe DW; Nichols FC
Infect Immun; 2010 Sep; 78(9):3726-35. PubMed ID: 20584977
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated dihydroceramides from common human bacteria are recovered in human tissues.
Nichols FC; Yao X; Bajrami B; Downes J; Finegold SM; Knee E; Gallagher JJ; Housley WJ; Clark RB
PLoS One; 2011 Feb; 6(2):e16771. PubMed ID: 21347306
[TBL] [Abstract][Full Text] [Related]
6. Potential Role of Phosphoglycerol Dihydroceramide Produced by Periodontal Pathogen
Yamada C; Akkaoui J; Ho A; Duarte C; Deth R; Kawai T; Nichols F; Lakshmana MK; Movila A
Front Immunol; 2020; 11():591571. PubMed ID: 33329577
[TBL] [Abstract][Full Text] [Related]
7. Porphyromonas gingivalis lipids and diseased dental tissues.
Nichols FC; Rojanasomsith K
Oral Microbiol Immunol; 2006 Apr; 21(2):84-92. PubMed ID: 16476017
[TBL] [Abstract][Full Text] [Related]
8. Free lipid A isolated from Porphyromonas gingivalis lipopolysaccharide is contaminated with phosphorylated dihydroceramide lipids: recovery in diseased dental samples.
Nichols FC; Bajrami B; Clark RB; Housley W; Yao X
Infect Immun; 2012 Feb; 80(2):860-74. PubMed ID: 22144487
[TBL] [Abstract][Full Text] [Related]
9. Glycine Lipids of Porphyromonas gingivalis Are Agonists for Toll-Like Receptor 2.
Nichols FC; Clark RB; Liu Y; Provatas AA; Dietz CJ; Zhu Q; Wang YH; Smith MB
Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932327
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 secretion from gingival fibroblasts treated with interleukin-1beta: effects of lipid extracts from Porphyromonas gingivalis or calculus.
Nichols FC; Levinbook H; Shnaydman M; Goldschmidt J
J Periodontal Res; 2001 Jun; 36(3):142-52. PubMed ID: 11453112
[TBL] [Abstract][Full Text] [Related]
11. Different engagement of TLR2 and TLR4 in Porphyromonas gingivalis vs. ligature-induced periodontal bone loss.
Lin M; Hu Y; Wang Y; Kawai T; Wang Z; Han X
Braz Oral Res; 2017 Aug; 31():e63. PubMed ID: 28832712
[TBL] [Abstract][Full Text] [Related]
12. Structures and biological activity of phosphorylated dihydroceramides of Porphyromonas gingivalis.
Nichols FC; Riep B; Mun J; Morton MD; Bojarski MT; Dewhirst FE; Smith MB
J Lipid Res; 2004 Dec; 45(12):2317-30. PubMed ID: 15466368
[TBL] [Abstract][Full Text] [Related]
13. Convergent synthesis of a deuterium-labeled serine dipeptide lipid for analysis of biological samples.
Dietz C; Clark RB; Nichols FC; Smith MB
J Labelled Comp Radiopharm; 2017 May; 60(6):274-285. PubMed ID: 28271544
[TBL] [Abstract][Full Text] [Related]
14. The role of RgpA in the pathogenicity of Porphyromonas gingivalis in the murine periodontitis model.
Wilensky A; Polak D; Houri-Haddad Y; Shapira L
J Clin Periodontol; 2013 Oct; 40(10):924-32. PubMed ID: 23909600
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
[TBL] [Abstract][Full Text] [Related]
16. The impact of Porphyromonas gingivalis lipids on apoptosis of primary human chondrocytes.
Röhner E; Hoff P; Matziolis G; Perka C; Riep B; Nichols FC; Kielbassa AM; Detert J; Burmester GR; Buttgereit F; Zahlten J; Pischon N
Connect Tissue Res; 2012; 53(4):327-33. PubMed ID: 22260531
[TBL] [Abstract][Full Text] [Related]
17. Diverse effects of Porphyromonas gingivalis on human osteoclast formation.
Scheres N; de Vries TJ; Brunner J; Crielaard W; Laine ML; Everts V
Microb Pathog; 2011 Sep; 51(3):149-55. PubMed ID: 21539907
[TBL] [Abstract][Full Text] [Related]
18. Porphyromonas gingivalis dihydroceramides induce apoptosis in endothelial cells.
Zahlten J; Riep B; Nichols FC; Walter C; Schmeck B; Bernimoulin JP; Hippenstiel S
J Dent Res; 2007 Jul; 86(7):635-40. PubMed ID: 17586710
[TBL] [Abstract][Full Text] [Related]
19. Lipidomic analysis of Porphyromonas gingivalis reveals novel glycerol bisphosphoceramide, phosphatidyl-, and phosphoglycerol dipeptide lipid families.
Kleiboeker BA; Frankfater C; Davey ME; Hsu FF
J Lipid Res; 2023 Dec; 64(12):100470. PubMed ID: 37924978
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 signaling contributes to alveolar bone resorption in Porphyromonas gingivalis-induced periodontitis in mice.
Nagashima H; Shinoda M; Honda K; Kamio N; Hasuike A; Sugano N; Arai Y; Sato S; Iwata K
J Oral Sci; 2017 Dec; 59(4):571-577. PubMed ID: 29093284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
